Subscribe to Newsletter

Content by Stephanie Vine:

Manufacture Advanced Medicine

Reactions to the UK’s Approval of a CRISPR Medicine

| Stephanie Vine | 3 min read

Scientists celebrate a new era of genetic medicine but what do we do about the costs?

Manufacture Advanced Medicine

The World’s First CRISPR-Based Therapeutic Approval

| Stephanie Vine | 3 min read

It’s official: CRISPR medicines are here as UK authorizes exa-cel.

Discovery & Development Ingredients

Manufacturers Urged to Take Steps to Avoid DEG and EG Contamination

| Stephanie Vine | 4 min read

Ongoing issues in the Asian pharma sector prompt an unequivocal response from the FDA and the IPEC Federation.

Business & Regulation Profession

Eight Articles to Celebrate Women in Pharma

| Stephanie Vine | 5 min read

Women still struggle to reach leadership positions in pharma. Now that we’ve acknowledged the issue, we can focus on overcoming it.

Business & Regulation Profession

Pfizer on Young Talent and Internships

| Stephanie Vine | 6 min read

There are myriad opportunities across different industries for young scientific talent. Why work in the pharma industry?

Discovery & Development Drug Discovery

Reaching for RNA

| Stephanie Vine | 7 min read

The COVID-19 pandemic has helped propel the RNA field forward, but manufacturing and funding challenges lie ahead.

Discovery & Development Drug Discovery

Nobel Prize for mRNA COVID-19 Vaccine Technology

| Stephanie Vine | 7 min read

Katalin Karikó and Drew Weissman win prestigious prize for persevering in a field that many ignored.

Manufacture Facilities

Taking Sustainability to Heart: An Interview With ten23 Health

| Stephanie Vine | 11 min read

We sit down with Hanns-Christian Mahler, CEO of ten23 health.

Manufacture Facilities

Center of Excellence Opens for RNA

| Stephanie Vine | 4 min read

UK-based center will have capacity for RNA therapeutic production for clinical trials and potential future health emergencies.

Discovery & Development Drug Discovery

Alzheimer’s Treatment Timeline

| Stephanie Vine | 2 min read

With new drugs showing promise for Alzheimer’s, is the drug development drought over?

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register